Spotify
Google Podcasts
Apple Podcasts
Breaker
Overcast
Pocket Casts
Radio Public
Anchor
aTyr Pharma Stock Forecast NASDAQ:LIFE
Price Target and Analyst Ratings
Historical Ratings
| Date | Upside / Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 2022-05-10 | 549.35% | RBC Capital | $22.00 $20.00 | Maintains | Outperform |
| 2021-11-11 | 257.14% | HC Wainwright & Co. | $18.00 $11.00 | Maintains | Buy |
| 2021-10-12 | 614.29% | RBC Capital | $22.00 | Initiates Coverage On | Outperform |
| 2021-09-21 | 516.88% | Piper Sandler | $19.00 | Initiates Coverage On | Overweight |
| 2021-09-14 | 581.82% | Roth Capital | $20.00 $21.00 | Maintains | Buy |
| 2021-09-14 | 549.35% | Oppenheimer | $14.00 $20.00 | Maintains | Outperform |
| 2021-09-13 | 484.42% | HC Wainwright & Co. | $13.00 $18.00 | Maintains | Buy |
| 2021-05-18 | 387.01% | JonesTrading | $15.00 | Initiates Coverage On | Buy |
| 2021-03-24 | 354.55% | Oppenheimer | $12.00 $14.00 | Maintains | Outperform |
| 2021-03-16 | 549.35% | Roth Capital | $15.00 $20.00 | Maintains | Buy |
| 2020-08-17 | 322.08% | HC Wainwright & Co. | $13.00 | Upgrades | Neutral Buy |
| 2020-03-27 | - | HC Wainwright & Co. | - | Downgrades | Buy Neutral |
| 2020-03-02 | 159.74% | Oppenheimer | $8.00 | Initiates Coverage On | Outperform |
| 2019-11-05 | 159.74% | HC Wainwright & Co. | $8.00 | Initiates Coverage On | Buy |
LIFE Stock Trend
The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $2.97 is broken, it will firstly indicate a stronger fall rate.
Given the current short-term trend, the stock is expected to fall -24.94% during the next 3 months and, with a 90% probability hold a price between $2.23 and $3.73 at the end of this 3-month period.
Data
| Date | Bottom | Mid | Top |
|---|---|---|---|
| 2022-05-18 | $2.94 | $3.94 | $4.94 |
| 2022-05-19 | $2.91 | $3.91 | $4.91 |
| 2022-05-20 | $2.88 | $3.88 | $4.88 |
| 2022-05-23 | $2.86 | $3.85 | $4.85 |
| 2022-05-24 | $2.83 | $3.83 | $4.83 |
| 2022-05-25 | $2.80 | $3.80 | $4.80 |
| 2022-05-26 | $2.77 | $3.77 | $4.77 |
| 2022-05-27 | $2.75 | $3.74 | $4.74 |
| 2022-05-31 | $2.72 | $3.72 | $4.72 |
| 2022-06-01 | $2.69 | $3.69 | $4.69 |
| 2022-06-02 | $2.66 | $3.66 | $4.66 |
| 2022-06-03 | $2.64 | $3.63 | $4.63 |
| 2022-06-06 | $2.61 | $3.61 | $4.61 |
| 2022-06-07 | $2.58 | $3.58 | $4.58 |
| 2022-06-08 | $2.55 | $3.55 | $4.55 |
| 2022-06-09 | $2.53 | $3.52 | $4.52 |
| 2022-06-10 | $2.50 | $3.50 | $4.50 |
| 2022-06-13 | $2.47 | $3.47 | $4.47 |
| 2022-06-14 | $2.44 | $3.44 | $4.44 |
| 2022-06-15 | $2.42 | $3.41 | $4.41 |
| 2022-06-16 | $2.39 | $3.39 | $4.39 |
| 2022-06-17 | $2.36 | $3.36 | $4.36 |
| 2022-06-21 | $2.33 | $3.33 | $4.33 |
| 2022-06-22 | $2.31 | $3.30 | $4.30 |
| 2022-06-23 | $2.28 | $3.28 | $4.28 |
| 2022-06-24 | $2.25 | $3.25 | $4.25 |
| 2022-06-27 | $2.22 | $3.22 | $4.22 |
| 2022-06-28 | $2.20 | $3.19 | $4.19 |
| 2022-06-29 | $2.17 | $3.17 | $4.17 |
| 2022-06-30 | $2.14 | $3.14 | $4.14 |
aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and clinical development of Physiocrine-based therapeutics for patients suffering from severe and rare diseases. The company develops Resolaris, which is in Phase Ib/II clinical trials for treating adult patients with facioscapulohumeral muscular dystrophy (FSHD), a rare genetic myopathy with an immune component; patients with early onset FSHD; and adult patients with limb-gir... Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!
Join 108 000+ Happy Subscribers
Don't miss out on the runners!
![StockInvest.us]()
Stock Podcast
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
